Does RISANKIZUMAB-RZAA Cause Haemoglobin increased? 8 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Haemoglobin increased have been filed in association with RISANKIZUMAB-RZAA. This represents 0.0% of all adverse event reports for RISANKIZUMAB-RZAA.
8
Reports of Haemoglobin increased with RISANKIZUMAB-RZAA
0.0%
of all RISANKIZUMAB-RZAA reports
0
Deaths
4
Hospitalizations
How Dangerous Is Haemoglobin increased From RISANKIZUMAB-RZAA?
Of the 8 reports, 4 (50.0%) required hospitalization.
Is Haemoglobin increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Haemoglobin increased?
RUXOLITINIB (332)
TREPROSTINIL (245)
SOTATERCEPT (151)
CLOZAPINE (142)
SOTATERCEPT-CSRK (100)
DARBEPOETIN ALFA (99)
TESTOSTERONE (96)
METFORMIN (93)
VOXELOTOR (86)
ROSUVASTATIN (85)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Haemoglobin increased Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA